Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition

Bioconjugate Chemistry

Volumn 18, Issue 5, 2007, Pages 1483-1489

  Mok, Hyejung ^a   Ji, Won Park ^a   Tae, Gwan Park ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; GENE EXPRESSION; HYALURONIC ACID; NUCLEIC ACIDS; ORGANIC ACIDS; SOLUTIONS; SULFUR COMPOUNDS;

ANTISENSE OLIGODEOXYNUCLEOTIDES; CELLULAR UPTAKE; DISULFIDE LINKAGES; GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN EXPRESSION; INHIBITION EFFICIENCY; NANOCOMPLEXES; OLIGODEOXYNUCLEOTIDES; POLYELECTROLYTE COMPLEXES; PROTEIN GENES;

POLYELECTROLYTES;

ANTISENSE OLIGODEOXYNUCLEOTIDE; BIOMATERIAL; CYTOTOXIC AGENT; GREEN FLUORESCENT PROTEIN; HYALURONIC ACID; NANOPARTICLE; POLYELECTROLYTE; POLYETHYLENEIMINE; PROTAMINE; SMALL INTERFERING RNA;

AQUEOUS SOLUTION; ARTICLE; CELL TRANSPORT; COMPLEX FORMATION; CONJUGATION; COVALENT BOND; DISULFIDE BOND; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOLECULAR STABILITY; NUCLEOTIDE METABOLISM; PROTEIN STABILITY; REDUCTION KINETICS; SURFACE CHARGE;

EID: 34648817050     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc070111o     Document Type: Article

References (34)

1. Jeong, J. H., Kim, S. W., and Park, T. G. (2003) Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. Bioconjugate Chem. 14, 473-479.
2. Vinogradov, S. V., Batrakova, E. V., Li, S., and Kabanov, A. V. (2004) Mixed polymer micelles of amphiphilic and cationic copolymers for delivery of antisense oligonucleotides. J. Drug Targeting 12, 517-526.
3. Kim, S. H., Jeong, J. H., Cho, K. C., Kim, S. W., and Park, T. G. (2005) Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J. Controlled Release 104, 223-232.
4. Kim, D. H., and Rossi, J. J. (2007) Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8, 173-184.
5. Zhao, X. B., and Lee, R. J. (2004) Tumor-selective targeted delivery of genes and antisense oligodeoxyribonucleotides via the folate receptor. Adv. Drug Delivery Rev. 56, 1193-1204.
6. Park, T. G., Jeong, J. H., and Kim, S. W. (2006) Current status of polymeric gene delivery systems. Adv. Drug Delivery Rev. 58, 467-486.
7. Oishi, M., Hayama, T., Akiyama, Y., Takae, S., Harada, A., Yamasaki, Y., Nagatsugi, F., Sasaki, S., Nagasaki, Y., and Kataoka, K. (2005) Supramolecular assemblies for the cytoplasmic delivery of antisense oligodeoxynucleotide: polyion complex (PIC) micelles based on poly(ethylene glycol)-SS- oligodeoxynucleotide conjugate. Biomacromolecules 6, 2449-2454.
8. Oishi, M., Nagasaki, Y., Itaka, K., Nishiyama, N., and Kataoka, K. (2005) Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J. Am. Chem. Soc. 127, 1624-1625.
9. Sagara, K., and Kim, S. W. (2002) A new synthesis of galactose- poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes. J. Controlled Release 79, 271-281.
10. Lee, H., Jeong, J. H., and Park, T. G. (2002) PEG grafted polylysine with fusogenic peptide for gene delivery: high transfection efficiency with low cytotoxicity. J. Controlled Release 79, 283-291.
11. Lee, M., and Kim, S. W. (2005) Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm. Res. 22, 1-10.
12. Putnam, D., Zelikin, A. N., Izumrudov, V. A., and Langer, R. (2003) Polyhistidine-PEG:DNA nanocomposites for gene delivery. Biomaterials 24, 4425-4433.
13. Choosakoonkriang, S., Lobo, B. A., Koe, G. S., Koe, J. G., and Middaugh, C. R. (2003) Biophysical characterization of PEI/DNA complexes. J. Pharm. Sci. 92, 1710-1722.
14. Christensen, L. V., Chang, C. W., Yockman, J. W., Conners, R., Jackson, H., Zhong, Z., Feijen, J., Bull, D. A., and Kim, S. W. (2007) Reducible poly(amido ethylenediamine) for hypoxia-inducible VEGF delivery. J. Controlled Release 118, 254-261.
15. Read, M. L., Bremner, K. H., Oupicky, D., Green, N. K., Searle, P. F., and Seymour, L. W. (2003) Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J. Gene Med. 5, 232-245.
16. Gosselin, M. A., Guo, W., and Lee, R. J. (2001) Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjugate Chem. 12, 989-994.
17. Read, M. L., Singh, S., Ahmed, Z., Stevenson, M., Briggs, S. S., Oupicky, D., Barrett, L. B., Spice, R., Kendall, M., Berry, M., Preece, J. A., Logan, A., and Seymour, L. W. (2005) A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res. 33, e86.
18. Meistrich, M. L., Mohapatra, B., Shirley, C. R., and Zhao, M. (2003) Roles of transition nuclear proteins in spermiogenesis. Chromosoma 111, 483-488.
19. Reynolds, F., Weissleder, R., and Josephson, L. (2005) Protamine as an efficient membrane-translocating peptide. Bioconjugate Chem. 16, 1240-1245.
20. Park, Y. J., Chang, L. C., Liang, J. F., Moon, C., Chung, C. P., and Yang, V. C. (2005) Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study. FASEB J. 19, 1555-1557.
21. Tsui, B., Singh, V. K., Liang, J. F., and Yang, V. C. (2001) Reduced reactivity towards anti-protamine antibodies of a low molecular weight protamine analogue. Thromb. Res. 101, 417-420.
22. Liang, J. F., Zhen, L., Chang, L. C., and Yang, V. C. (2003) A less toxic heparin antagonist-low molecular weight protamine. Biochemistry (Mosc.) 68, 116-120.
23. Masuda, T., Akita, H., and Harashima, H. (2005) Evaluation of nuclear transfer and transcription of plasmid DNA condensed with protamine by microinjection: the use of a nuclear transfer score. FEBS Lett. 579, 2143-2148.
24. Dinauer, N., Lochmann, D., Demirhan, I., Bouazzaoui, A., Zimmer, A., Chandra, A., Kreuter, J., and von Briesen, H. (2004) Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation. J. Controlled Release 96, 497-507.
25. Glodde, M., Sirsi, S. R., and Lutz, G. J. (2006) Physiochemical properties of low and high molecular weight poly(ethylene glycol)-grafted poly(ethylene imine) copolymers and their complexes with oligonucleotides. Biomacromolecules 7, 347-356.
26. Kim, S. H., Mok, H., Jeong, J. H., Kim, S. W., and Park, T. G. (2006) Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate. Bioconjugate Chem. 17, 241-244.
27. Wang, W., and Ballatori, N. (1998) Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol. Rev. 50, 335-356.
28. Jeong, J. H., Kim, S. W., and Park, T. G. (2003) Novel intracellular delivery system of antisense oligonucleotide by self-assembled hybrid micelles composed of DNA/PEG conjugate and cationic fusogenic peptide. Bioconjugate Chem. 14, 473-479.
29. Cherng, J. Y., van de Wetering, P., Talsma, H., Crommelin, D. J., and Hennink, W. E. (1996) Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm. Res. 13, 1038-1042.
30. Kunath, K., von Harpe, A., Fischer, D., Petersen, H., Bickel, U., Voigt, K., and Kissel, T. (2003) Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J. Controlled Release 89, 113-125.
31. Luo, Y., Ziebell, M. R., and Prestwich, G. D. (2000) A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells. Biomacromolecules 1, 208-218.
32. Jaracz, S., Chen, J., Kuznetsova, L. V., and Ojima, I. (2005) Recent advances in tumor-targeting anticancer drug conjugates. Bioorg. Med. Chem. 13, 5043-5054.
33. Takei, Y., Maruyama, A., Ferdous, A., Nishimura, Y., Kawano, S., Ikejima, K., Okumura, S., Asayama, S., Nogawa, M., Hashimoto, M., Makino, Y., Kinoshita, M., Watanabe, S., Akaike, T., Lemasters, J. J., and Sato, N. (2004) Targeted gene delivery to sinusoidal endothelial cells: DNA nanoassociate bearing hyaluronan-glycocalyx. FASEB J. 18, 699-701.
34. Lee, H., Mok, H., Lee, S., Y-K Oh, and Park T. G. (2007) Hyaluronic acid nanogels for target-specific intracellular delivery of siRNA. J. Controlled Release 119, 245-252.